Why the Facility of the Year Awards are Important to Pharma Industry
ISPE’s Facility of the Year Awards (FOYA) program recognizes the shared commitment and dedication of companies worldwide, to enhance patient health and safety through innovation and advancement.
“The FOYA Award is important [to the] industry as a whole because it provides a platform to share knowledge and experience,” said Ryan Hawkins, Vice President and Chief Operating Officer, Cook Pharmica, LLC, 2017 FOYA Category Winner for Equipment Innovation.
“If you think about it, where else can you get that type of snapshot of major projects, of major technological advances in [the] industry, [and it] also says a lot about the importance of the FOYA awards,” said Hawkins.
Christopher Sweeney, Senior General Manager, Pt Kalbio Global Medika, 2017 FOYA Honorable Mention shared, “The reason why we joined the FOYA awards was that we’re very proud of our facility and we wanted to show the industry that in Indonesia, we can build the equivalent, or even better of some of the facilities in the West.”
The Facility of the Year Awards category winners represent the epitome of companies who utilize pioneering technology and design to help set the standard for future pharmaceutical facilities.
“We really felt that [it] was a vindication of our design and our hard work, and it gave confidence to the parent company to expand our operations,” said Sweeney.
“Being a winner of the FOYA award, and being worthy of that distinction, means a lot,” said Hawkins. “What it means, is we’re becoming operational, and with the purpose of serving more customers and therefore more patients.”
The 2017 FOYA Facility of the Future and Overall Winner was awarded to Eli Lilly and Company. “[We] appreciate ISPE for leading the industry towards where we want to go,” said David Sternasty, Vice President of Corporate Engineering and Global Health, Safety and Environment.
As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased...
At the 2024 ISPE Europe Annual Conference, held in Lisbon, Portugal, 16-18 April, Richard L. Friedman, MS, Deputy Director of the US Food and Drug Administration’s (US FDA) Office of Manufacturing Quality, in...
Insight from Austria’s Regulatory Authority Representative
At the 2024 ISPE Aseptic Conference, held March 12-13 in Vienna, Austria, Christina Meissner, a European Union Good Manufacturing Practice (GMP) inspector at the Austrian Agency for Health and Food Safety since 2013, and Chair of the PIC/S Drafting Group on Annex 2A and 2B, published in May 2021, offered a presentation titled...